NEW YORK ( TheStreet) -- BioMarin Pharmaceuticals (Nasdaq: BMRN) hit a new 52-week high Monday as it is currently trading at $42.38, above its previous 52-week high of $42.37 with two million shares traded as of 1:45 p.m. ET. Average volume has been 1.5 million shares over the past 30 days. BioMarin has a market cap of $4.81 billion and is part of the health care sector and drugs industry. Shares are up 18.6% year to date as of the close of trading on Friday. BioMarin Pharmaceutical Inc. develops and commercializes biopharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and rest of the world.
- ACTIVE STOCK TRADERS: Check out TheStreet's special offer for Real Money, headlined by Jim Cramer, now!